Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction.
Stepan H, Galindo A, Hund M, Schlembach D, Sillman J, Surbek D, Vatish M.
Stepan H, et al.
Ultrasound Obstet Gynecol. 2023 Feb;61(2):168-180. doi: 10.1002/uog.26032.
Ultrasound Obstet Gynecol. 2023.
PMID: 35816445
Free article.
Review.
It has clinical value because it can rule out the development of PE in the 1-4-week period after the test. Once a diagnosis of PE is established, repeat measurement of sFlt-1 and PlGF can help monitor progression of the condition and may inform clinical decision-making reg …
It has clinical value because it can rule out the development of PE in the 1-4-week period after the test. Once a diagnosis of PE is …